Liisa Valsta

Liisa Valsta

Auto-generated profile, based on publicly available information

Liisa Valsta

Finnish Institute for Health and Welfare Helsinki Finland

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2020 in Thyroid®
Verified
Journal Article
Closed access
TITill Ittermann
Till Ittermann
DADiana Albrecht
Diana Albrecht
PAPetra Arohonka
Petra Arohonka
RBR. Bílek
R. Bílek
JCJoao J. de Castro
Joao J. de Castro
HVHenry Völzke
Henry Völzke
Background: Knowledge about the population's iodine status is important, because it allows adjustment of iodine supply and prevention of iodine deficiency. The validity and comparability of iodine-related population studies can be improved by standardization, which was one of the goals of the EUthyroid project. The aim of this study was to establish the first standardized map of iodine status in Europe by using standardized urinary iodine concentration (UIC) data. Materials and Methods: We established a gold-standard laboratory in Helsinki measuring UIC by inductively coupled plasma mass spectrometry. A total of 40 studies from 23 European countries provided 75 urine samples covering the whole range of concentrations. Conversion formulas for UIC derived from the gold-standard values were established by linear regression models and were used to postharmonize the studies by standardizing the UIC data of the individual studies. Results: In comparison with the EUthyroid gold-standard, mean UIC measurements were higher in 11 laboratories and lower in 10 laboratories. The mean differences ranged from −36.6% to 49.5%. Of the 40 postharmonized studies providing data for the standardization, 16 were conducted in schoolchildren, 13 in adults, and 11 in pregnant women. Median standardized UIC was <100 μg/L in 1 out of 16 (6.3%) studies in schoolchildren, while in adults 7 out of 13 (53.8%) studies had a median standardized UIC <100 μg/L. Seven out of 11 (63.6%) studies in pregnant women revealed a median UIC <150 μg/L. Conclusions: We demonstrate that iodine deficiency is still present in Europe, using standardized data from a large number of studies. Adults and pregnant women, particularly, are at risk for iodine deficiency, which calls for action. For instance, a more uniform European legislation on iodine fortification is warranted to ensure that noniodized salt is replaced by iodized salt more often. In addition, further efforts should be put on harmonizing iodine-related studies and iodine measurements to improve the validity and comparability of results.

1 June 2010 in Public Health Nutrition
Verified
Journal Article
Open access
PDF file
LVLiisa M Valsta
Liisa M Valsta
HTHeli Tapanainen
Heli Tapanainen
JSJouko Sundvall
Jouko Sundvall
TLTiina Laatikainen
Tiina Laatikainen
SMSatu Männistö
Satu Männistö
EVErkki Vartiainen
Erkki Vartiainen
Objective: To assess to what extent the observed dietary changes and increased use of lipid-lowering medication can explain the almost 20 % decline in serum cholesterol (referring to serum total cholesterol) level observed from 1982 to 2007 in Finland.Design: Predicted changes of serum cholesterol were calculated by the Keys’ equation assuming the effect of trans fatty acids to be similar to SFA and using the dietary intake data of the national dietary surveys between 1982 and 2007. The effect of medication was estimated based on the information on use of lipid-lowering medication among survey participants. The predicted serum cholesterol levels were compared with observed changes in analysed serum cholesterol levels.Setting: Four cross-sectional population surveys, in 1982, 1992, 2002 and 2007, in the provinces of North Karelia, Northern Savo and Southwestern Finland.Subjects: A total of 2325 men and 2638 women aged 26–64 years selected randomly from the national population register for the four surveys.Results: Changes in dietary fat quality and cholesterol intake explain 0·70 mmol/l (65 %) of the decrease in men and 0·65 mmol/l (60 %) of the decrease in women in all subjects. Decline in dietary SFA intake is the main explanatory factor (47 % in men and 41 % in women) for the changes. The impact of lipid-lowering medication on observed cholesterol levels was found to be 16 % among men and 7 % among women.Conclusions: The decrease in serum cholesterol levels in Finland can be explained mainly by dietary changes, especially changes in fat quality. The effect of lipid-lowering medication is less significant.

23 March 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
LVLiisa M. Valsta
Liisa M. Valsta
HTHeli Tapanainen
Heli Tapanainen
TKTeea Kortetmäki
Teea Kortetmäki
LSLaura Sares-Jäske
Laura Sares-Jäske
LPLaura Paalanen
Laura Paalanen
MKMinna Kaljonen
Minna Kaljonen
Information on dietary adequacy is needed to assess food and nutrition security in a modern society, especially in the transition towards climate-friendly food systems. In this study, differences in the nutritional adequacy of diets among Finnish adults were evaluated in population groups of different education, income and urbanisation levels. The study used data from the FinDiet 2017 Survey (n = 1655, 18–74 years). Modelled usual intakes of foods and nutrients were evaluated relative to food-based dietary guidelines issued by the National Nutrition Council of Finland (FNNC) and with respect to nutrient adequacy following the Nordic Nutrition Recommendations and FNNC. For about half of the nutrients studied, intakes were found to be adequate. Intakes of protein, fat, saturated fatty acids and salt were estimated to be high. By contrast, inadequate intakes were seen in folate and vitamins A, D, B1, B2 and C in almost all groups studied. Groups with a higher education and income, groups that lived in urban areas and, in particular, women adhered more closely to recommended food consumption and nutrient intakes than others. However, major challenges posed by the Finnish diet are common to all groups studied, and only certain dietary features evaluated in view of nutritional adequacy are associated with socioeconomic differences.

1 September 2006 in Genes & Nutrition
Verified
Journal Article
Open access
PDF file
NSN. M. Saarinen
N. M. Saarinen
CBC. Bingham
C. Bingham
SLStefano Lorenzetti
Stefano Lorenzetti
AMA. Mortensen
A. Mortensen
SMS. Mäkelä
S. Mäkelä
OZO. Zierau
O. Zierau
Phytoestrogens are naturally occurring plantderived polyphenols with estrogenic potency. They are ubiquitous in diet and therefore, generally consumed. Among Europeans, the diet is rich in multiple putative phytoestrogens including flavonoids, tannins, stilbenoids, and lignans. These compounds have been suggested to provide beneficial effects on multiple menopause-related conditions as well as on development of hormone-dependent cancers, which has increased the interest in products and foods with high phytoestrogen content. However, phytoestrogens may as well have adverse estrogenicity related effects similar to any estrogen. Therefore, the assessment of estrogenic potency of dietary compounds is of critical importance. Due to the complex nature of estrogenicity, no single comprehensive test approach is available. Instead, several in vitro and in vivo assays are applied to evaluate estrogenic potency. In vitro estrogen receptor (ER) binding assays provide information on the ability of the compound to I) interact with ERs, II) bind to estrogen responsive element on promoter of the target gene as ligand-ER complex, and III) interact between the co-activator and ERs in ligand-dependent manner. In addition, transactivation assays in cells screen for ligand-induced ERmediated gene activation. Biochemical in vitro analysis can be used to test for possible effects on protein activities and E-screen assays to measure (anti)proliferative response in estrogen responsive cells. However, for assessment of estrogenicity in organs and tissues, in vivo approaches are essential. In females, the uterotrophic assay is applicable for testing ERa agonistic and antagonistic dietary compounds in immature or adult ovariectomized animals. In addition, mammary gland targeted estrogenicity can be detected as stimulated ductal elongation and altered formation of terminal end buds in immature or peripubertal animals. In males, Hershberger assay in peri-pubertal castrated rats can be used to detect (anti)androgenic/ (anti)estrogenic responses in accessory sex glands and other hormone regulated tissues. In addition to these short-term assays, sub-acute and chronic reproductive toxicity assays as well as two-generation studies can be applied for phytoestrogens to confirm their safety in long-term use. For reliable assessment of estrogenicity of dietary phytoestrogens in vivo, special emphasis should be focused on selection of the basal diet, route and doses of administration, and possible metabolic differences between the species used and humans. In conclusion, further development and standardization of the estrogenicity test methods are needed for better interpretation of both the potential benefits and risks of increasing consumption of phytoestrogens from diets and supplements.

JSJohanna Suomi
Johanna Suomi
LVLiisa Valsta
Liisa Valsta
PTPirkko Tuominen
Pirkko Tuominen
For the non-smoking and non-occupationally exposed population in Europe, food is the main source of heavy metal exposure. The aim of the study was to estimate the dietary exposure of the Finnish adult population to cadmium, lead, inorganic arsenic, inorganic mercury and methyl mercury as well as nickel using governmental as well as industry data on heavy metal occurrence in foodstuffs and the data from two national food consumption surveys conducted in 2007 and 2012. The sources of heavy metal exposure were estimated for the working-age population (25 to 64 years) and for the elderly (65 to 74 years). Exposure differences between years and between population groups were compared statistically. The mean exposure of women aged 25 to 45 years to cadmium and lead was statistically significantly (p < 0.001) higher, and the methyl mercury exposure lower (p = 0.001) than that of women aged 46 to 64 years. For nickel and inorganic arsenic the differences were lower but still statistically significant (p < 0.05). Between genders, significant difference (p < 0.05) was only seen for lead and nickel. Mean cadmium exposure was significantly higher in 2012 than in 2007. For at least 95% of the adult population, the risk of health damage from mercury or nickel exposure is negligible, but the margin of exposure for lead and inorganic arsenic is small and shows a possible risk of cancer or neurotoxic effects.

1 January 1997 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
QMQing‐He Meng
Qing‐He Meng
PPP. Pajukanta
P. Pajukanta
LVL. Valsta
L. Valsta
AAA. Aro
A. Aro
PPP. Pietinen
P. Pietinen
MTM. J. Tikkanen
M. J. Tikkanen
Objectives. To analyse the association between the G/A polymorphism in the apolipoprotein A‐1 (apo A‐1) promoter region and plasma lipid levels, as well as their responses to dietary change, in Finnish adults. Subjects and design. Blood samples from 86 subjects (42 men, 44 women) who attended a dietary intervention study carried out in North Karelia in 1993 were available for the current analysis. The diet study consisted of a 2‐week baseline period, followed by an 8‐week intervention period, and an 8‐week switchback period. Intervention. Diet was modified to a low‐fat, low‐cholesterol diet during the dietary intervention. Main outcome measures. Fasting plasma lipid, lipoprotein and apolipoprotein levels were determined. Results. At baseline, the high‐density lipoprotein (HDL) cholesterol and apo A‐1 levels were higher (P<0.01) and the triglyceride levels were lower (P<0.05) in men, but not in women, with the A allele. The differences in HDL cholesterol and apo A‐1 levels between genotypes remained during the low‐fat, low‐cholesterol diet and switchback periods. Apart from the difference between responses in apo A‐1 during switchback to the original diet, lipid responses to dietary change did not differ significantly between genotypes. Conclusion. Our findings indicate a significant association between the apo A‐1 promoter polymorphism and plasma apo A‐1 and HDL‐cholesterol in men. In theory, the higher plasma HDL‐cholesterol and apo A‐1 levels in the GA/AA group may confer some protection against coronary artery disease. The differences in HDL‐cholesterol and apo A‐1 levels between genotypes persisted during different diets suggesting that the possible benefit is independent of fat and cholesterol intake.